Kits Eyecare Ltd (KITS)

Currency in CAD
18.95
+0.48(+2.60%)
Closed·
KITS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
18.3719.10
52 wk Range
8.5522.56
Key Statistics
Bid/Ask
18.83 / 19.06
Prev. Close
18.47
Open
18.37
Day's Range
18.37-19.1
52 wk Range
8.55-22.56
Volume
47.45K
Average Volume (3m)
92.1K
1-Year Change
112.9213%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
KITS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
23.50
Upside
+24.01%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Kits Eyecare Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell

Kits Eyecare Company Profile

Kits Eyecare Ltd. operates a digital eyecare platform in the United States and Canada. It manufactures progressive and contact lenses, eyeglasses, and frames under the KITS brand, as well as distributes eyewear products of various brands. The company operates a network of optical e-commerce websites, including KITS.com, KITS.ca, OptiContacts.com, and ContactsExpress.ca. Kits Eyecare Ltd. was founded in 2002 and is headquartered in Vancouver, Canada.

Employees
162
Market
Canada

Kits Eyecare Ltd Earnings Call Summary for Q3/2025

  • Kits Eyecare reported Q3 2025 revenue of CAD 52.4M (+25% YoY) with EPS of CAD 0.06, exceeding forecasts despite a 4.32% stock decline in after-hours trading.
  • Gross margins expanded to 34.6% (+170 basis points), while adjusted EBITDA reached CAD 2.9M (+79% YoY), marking the 12th consecutive quarter of positive adjusted EBITDA.
  • The Canadian market showed robust 38% YoY growth, with repeat customers accounting for 62.4% of total revenue, demonstrating strong customer retention.
  • Management forecasts Q4 revenue between CAD 52-54M with adjusted EBITDA margin of 4-6%, targeting 25-30% growth over the next year.
  • CEO Roger Hardy emphasized technological advancement and AI innovation, with plans to reinvest in the U.S. market while maintaining marketing spend at 13-15% of revenue.
Last Updated: 06/11/2025, 23:42
Read Full Transcript

Compare KITS to Peers and Sector

Metrics to compare
KITS
Peers
Sector
Relationship
P/E Ratio
109.2x17.0x11.2x
PEG Ratio
0.060.010.02
Price/Book
9.8x2.1x1.4x
Price / LTM Sales
3.1x1.2x1.0x
Upside (Analyst Target)
21.4%26.9%21.8%
Fair Value Upside
Unlock11.0%9.4%Unlock

Analyst Ratings

7 Buy
0 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 23.50
(+24.01% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Desjardins
Buy23.00+21.37%-Maintain27/10/2025
Stifel Canada
Buy22.00+16.09%18.00Maintain07/08/2025
Desjardins
Buy23.00+21.37%-New Coverage24/07/2025
Canaccord Genuity
Buy14.50-23.48%-Maintain26/03/2025
Stifel Canada
Buy18.00-5.01%-Maintain17/03/2025

Earnings

Latest Release
Nov 06, 2025
EPS / Forecast
0.06 / 0.0529
Revenue / Forecast
52.39M / 52.91M
EPS Revisions
Last 90 days

People Also Watch

27.720
VNP
+5.56%
2.7000
BRM
+1.12%

FAQ

What Is the Kits Eyecare (KITS) Share Price Today?

The live Kits Eyecare share price today is 18.95

What Stock Exchange Does Kits Eyecare (KITS) Trade On?

Kits Eyecare is listed and trades on the Toronto Stock Exchange.

What Is the Ticker (Stock Symbol) for Kits Eyecare?

The stock symbol (also called a 'ticker') for Kits Eyecare is "KITS."

What Is the Current Kits Eyecare Market Cap?

As of today, Kits Eyecare market capitalisation is 609.07M.

What Is Kits Eyecare's (KITS) Earnings Per Share (TTM)?

The Kits Eyecare EPS is currently 0.16 (Trailing Twelve Months).

When Is the Next Kits Eyecare Earnings Date?

Kits Eyecare's next earnings report will be released on 11/03/2026.

Is KITS a Buy or Sell From a Technical Analyst Perspective?

Based on today's Kits Eyecare moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Kits Eyecare Stock Split?

Kits Eyecare has split 0 times. (See the KITS stock split history page for full effective split date and price information.)

How Many Employees Does Kits Eyecare Have?

Kits Eyecare has 162 employees.

What is the current trading status of Kits Eyecare (KITS)?

As of 16/02/2026, Kits Eyecare (KITS) is trading at a price of 18.95, with a previous close of 18.47. The stock has fluctuated within a day range of 18.37 to 19.10, while its 52-week range spans from 8.55 to 22.56.

What Is Kits Eyecare (KITS) Price Target According to Analysts?

The average 12-month price target for Kits Eyecare is CAD23.50, with a high estimate of CAD26 and a low estimate of CAD21.5. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +24.01% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.